Semaglutide reaches steady-state plasma concentration after roughly 4 to 5 weeks of consistent weekly dosing at any dose
After 26, 64 and 76 weeks, 1,392, 359 and 185 patients, respectively, were still taking part in the programme
Who May Need Extra Caution Patients with heart failure, certain arrhythmias, or unstable cardiac conditions may be more vulnerable if their resting heart rate rises
Ozempic and Rybelsus are approved for type-2 diabetes, while Wegovy is approved for chronic weight management
People on blood thinners or with clotting disorders should also report unexpected bruising early
Microdosing starts at 0.125 mg (sometimes even lower) and increases in smaller increments